Goldman Sachs Adjusts Price Target on MSCI to $672 From $671

Goldman Sachs raised its price target for MSCI from $671 to $672. The stock is currently trading at $550.76, down 0.75% on the day but up 2.38% over the past year. Wells Fargo also recently adjusted its target for MSCI, lowering it from $690 to $685 while maintaining an Overweight rating.

Original reporting
Published Oct 7, 2026, 2:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MSCI
Neutral
high confidence
Mentioned
$MSCI
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$MSCINeutralLow
01

Why it matters

The $1 raise is unlikely to affect MSCI's price in the short term, but it confirms a stable outlook.

02

Market read

Minor analyst update with limited trading relevance.

03

What to watch

Potential upcoming earnings or macro data could outweigh the minor target adjustment.

Relevance 5/10Novelty 6/10Timing: today

Background

Goldman Sachs periodically updates price targets for covered stocks; this is a routine analyst action.

Company-level read

Ticker impact

$MSCINeutralHigh confidence
Context

Goldman Sachs raised MSCI's price target to $672 from $671, providing fresh analyst guidance.

Expected impact

minimal impact, likely neutral as the change is marginal.

Evidence & confidence

Target move is only $1, which is too small to drive significant buying or selling pressure.

Market effects

None significant; MSCI operates in the index and analytics sector, and a $1 target tweak does not alter sector outlook.

US market only; no broader regional effect.

Limited, as MSCI is a large-cap but the guidance change is marginal.

Counterpoint

Investors may view the tiny increase as a signal that the stock is already fairly valued and could be a sell signal.

Key entities

  • Goldman Sachs

    Equity research firm that issued the price target update.

  • MSCI Inc.

    Provider of investment decision support tools and indices.

Related articles

Med

India's Swiggy pares gains ahead of exit from MSCI indexes

Swiggy's shares closed 2.5% higher on Friday, after rising as much as 5.61%, ahead of being removed from MSCI indexes. The firm faces an estimated $360 million in passive outflows, according to Nuvama's Abhilash Pagaria. Swiggy's shares have fallen 28.5% this year, underperforming the Nifty mid-cap 100 index.

MedAI 8/10

MSCI August Rebalance and Jio IPO Approval to Test Market

MSCI's August 2026 index rebalance, effective September 1, 2026, will shift $1.5B in passive funds, adding Laurus Labs, Lenskart, Adani Energy, and Billionbrains, while removing Balkrishna, SBI Cards, and Astral. Jio Platforms' IPO, approved by SEBI, aims to raise ₹27,500 crore. New closing auction rules may increase volatility.

$MSTRMed

MicroStrategy Bitcoin: MSCI Index Review Could Pressure Shares

MSCI is reviewing rules that could remove MicroStrategy from global equity indexes, focusing on companies primarily engaged in asset accumulation. MicroStrategy shares rose 35% in a week but are down 60% year-over-year. The review uses five financial metrics to assess eligibility, potentially affecting demand and capital access for MicroStrategy's Bitcoin purchases.

$MSCIHighAI 8/10

Are Wall Street Analysts Bullish on MSCI Stock?

MSCI Inc. (MSCI), a data and analytics provider, has underperformed the broader market over the past year. Its shares fell 10.1% on July 21 after raising its 2026 operating expense forecast, citing higher costs. Analysts expect MSCI's adjusted EPS to grow 13.5% YoY to $19.61. The consensus rating is 'Strong Buy' with a mean price target of $690.44, a 22.5% premium to current levels.